Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Chemical Actions and Uses > Toxic Actions > Noxae > Antimetabolites > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Molecular Mechanisms of Pharmacological Action > Antimetabolites > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Therapeutic Uses > Lipid Regulating Agents > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Molecular Mechanisms of Pharmacological Action > Enzyme Inhibitors > Protease Inhibitors > Serine Proteinase Inhibitors > PCSK9 Inhibitors

Preferred term

PCSK9 Inhibitors  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Cardiovascular PCSK9 Inhibitors
  • Inhibitors, Cardiovascular PCSK9
  • PCSK9 Inhibitors, Cardiovascular

Scope note

  • Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.

History note

  • 2022

In other languages

URI

http://www.yso.fi/onto/mesh/D000091362

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/9/21, last modified 7/8/21